340 related articles for article (PubMed ID: 29121766)
1. Percutaneous coronary intervention reduces mortality in myocardial infarction patients with comorbidities: Implications for elderly patients with diabetes or kidney disease.
Dégano IR; Subirana I; Fusco D; Tavazzi L; Kirchberger I; Farmakis D; Ferrières J; Azevedo A; Torre M; Garel P; Brosa M; Davoli M; Meisinger C; Bongard V; Araújo C; Lekakis J; Francès A; Castell C; Elosua R; Marrugat J;
Int J Cardiol; 2017 Dec; 249():83-89. PubMed ID: 29121766
[TBL] [Abstract][Full Text] [Related]
2. Non-ST-Segment-Elevation Myocardial Infarction Among Patients With Chronic Kidney Disease: A Propensity Score-Matched Comparison of Percutaneous Coronary Intervention Versus Conservative Management.
Bhatia S; Arora S; Bhatia SM; Al-Hijji M; Reddy YNV; Patel P; Rihal CS; Gersh BJ; Deshmukh A
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29525779
[TBL] [Abstract][Full Text] [Related]
3. Management and outcomes of acute myocardial infarction in patients with chronic kidney disease.
Smilowitz NR; Gupta N; Guo Y; Mauricio R; Bangalore S
Int J Cardiol; 2017 Jan; 227():1-7. PubMed ID: 27846456
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014.
Ismail MD; Jalalonmuhali M; Azhari Z; Mariapun J; Lee ZV; Zainal Abidin I; Wan Ahmad WA; Zuhdi ASM;
BMC Cardiovasc Disord; 2018 Sep; 18(1):184. PubMed ID: 30249197
[TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease and diabetes associated with long-term outcomes in patients receiving percutaneous coronary intervention.
Lin MJ; Lee J; Chen CY; Huang CC; Wu HP
BMC Cardiovasc Disord; 2017 Sep; 17(1):242. PubMed ID: 28893175
[TBL] [Abstract][Full Text] [Related]
6. Left circumflex artery-related myocardial infarction: does ST elevation matter? Results from the Euro Heart Survey PCI registry.
Bauer T; Gitt AK; Hochadel M; Möllmann H; Nef H; Weidinger F; Zahn R; Hamm CW; Marco J; Zeymer U
Int J Cardiol; 2013 Oct; 168(6):5239-42. PubMed ID: 23998547
[TBL] [Abstract][Full Text] [Related]
7. Temporal Trends in Utilization of Cardiac Therapies and Outcomes for Myocardial Infarction by Degree of Chronic Kidney Disease: A Report From the NCDR Chest Pain-MI Registry.
Bagai A; Lu D; Lucas J; Goyal A; Herzog CA; Wang TY; Goodman SG; Roe MT
J Am Heart Assoc; 2018 Dec; 7(24):e010394. PubMed ID: 30514137
[TBL] [Abstract][Full Text] [Related]
8. Impact of Chronic Kidney Disease on Utilization of Coronary Angiography and Percutaneous Coronary Intervention, and Their Outcomes in Patients With Non-ST Elevation Myocardial Infarction.
Murray J; Balmuri A; Saurav A; Smer A; Alla VM
Am J Cardiol; 2018 Dec; 122(11):1830-1836. PubMed ID: 30336930
[TBL] [Abstract][Full Text] [Related]
9. The impact of stage of chronic kidney disease on the outcomes of diabetics with acute myocardial infarction treated with percutaneous coronary intervention.
Vichova T; Knot J; Ulman J; Maly M; Motovska Z
Int Urol Nephrol; 2016 Jul; 48(7):1137-43. PubMed ID: 26995007
[TBL] [Abstract][Full Text] [Related]
10. Trends of Incidence, Clinical Presentation, and In-Hospital Mortality Among Women With Acute Myocardial Infarction With or Without Spontaneous Coronary Artery Dissection: A Population-Based Analysis.
Mahmoud AN; Taduru SS; Mentias A; Mahtta D; Barakat AF; Saad M; Elgendy AY; Mojadidi MK; Omer M; Abuzaid A; Agarwal N; Elgendy IY; Anderson RD; Saw J
JACC Cardiovasc Interv; 2018 Jan; 11(1):80-90. PubMed ID: 29248409
[TBL] [Abstract][Full Text] [Related]
11. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.
Miyachi H; Takagi A; Miyauchi K; Yamasaki M; Tanaka H; Yoshikawa M; Saji M; Suzuki M; Yamamoto T; Shimizu W; Nagao K; Takayama M
Heart Vessels; 2016 Nov; 31(11):1740-1751. PubMed ID: 26758733
[TBL] [Abstract][Full Text] [Related]
12. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
[TBL] [Abstract][Full Text] [Related]
13. Are there sex differences in the effect of type 2 diabetes in the incidence and outcomes of myocardial infarction? A matched-pair analysis using hospital discharge data.
Lopez-de-Andres A; Jimenez-Garcia R; Hernández-Barrera V; de Miguel-Yanes JM; Albaladejo-Vicente R; Villanueva-Orbaiz R; Carabantes-Alarcon D; Zamorano-Leon JJ; Lopez-Herranz M; de Miguel-Diez J
Cardiovasc Diabetol; 2021 Apr; 20(1):81. PubMed ID: 33888124
[TBL] [Abstract][Full Text] [Related]
14. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry.
Fox CS; Muntner P; Chen AY; Alexander KP; Roe MT; Cannon CP; Saucedo JF; Kontos MC; Wiviott SD;
Circulation; 2010 Jan; 121(3):357-65. PubMed ID: 20065168
[TBL] [Abstract][Full Text] [Related]
15. Impact of chronic kidney disease on clinical outcomes in patients with non-ST elevation myocardial infarction receiving percutaneous coronary intervention - A five-year observational study.
Wang HT; Chen YL; Wu CJ
Int J Cardiol; 2016 Oct; 220():166-72. PubMed ID: 27379919
[TBL] [Abstract][Full Text] [Related]
16. Temporal trends and in-hospital outcomes of primary percutaneous coronary intervention in nonagenarians with ST-segment elevation myocardial infarction.
Kim JY; Jeong MH; Choi YW; Ahn YK; Chae SC; Hur SH; Hong TJ; Kim YJ; Seong IW; Chae IH; Cho MC; Yoon JH; Seung KB;
Korean J Intern Med; 2015 Nov; 30(6):821-8. PubMed ID: 26552457
[TBL] [Abstract][Full Text] [Related]
17. Increasing percutaneous coronary interventions for ST-segment elevation myocardial infarction in the United States: progress and opportunity.
Shah RU; Henry TD; Rutten-Ramos S; Garberich RF; Tighiouart M; Bairey Merz CN
JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):139-146. PubMed ID: 25616918
[TBL] [Abstract][Full Text] [Related]
18. Impact of diabetes and hypertension on cardiovascular outcomes in patients with coronary artery disease receiving percutaneous coronary intervention.
Lin MJ; Chen CY; Lin HD; Wu HP
BMC Cardiovasc Disord; 2017 Jan; 17(1):12. PubMed ID: 28056847
[TBL] [Abstract][Full Text] [Related]
19. Sex-related differences after contemporary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Barthélémy O; Degrell P; Berman E; Kerneis M; Petroni T; Silvain J; Payot L; Choussat R; Collet JP; Helft G; Montalescot G; Le Feuvre C
Arch Cardiovasc Dis; 2015; 108(8-9):428-36. PubMed ID: 25937358
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Coronary Artery Disease and Acute Myocardial Infarction in Hospitals With and Without On-Site Coronary Artery Bypass Graft Surgery.
Hannan EL; Zhong Y; Wu Y; Berger PB; Jacobs AK; Walford G; Venditti FJ; Ling FSK; Tamis-Holland J; King SB
Circ Cardiovasc Interv; 2019 Jan; 12(1):e007097. PubMed ID: 30616362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
